This Article
Right arrow Full Text (PDF)
Right arrow A correction has been published
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Johnson, R C
Right arrow Articles by Russell, M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Johnson, R C
Right arrow Articles by Russell, M

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1987 February; 31(2): 164-167

In vitro and in vivo susceptibility of the Lyme disease spirochete, Borrelia burgdorferi, to four antimicrobial agents.

R C Johnson, C Kodner and M Russell

ABSTRACT

The antimicrobial susceptibility of Borrelia burgdorferi isolated from human spinal fluid was determined in vitro and in vivo. A broth dilution technique was used to determine the MBCs of four antimicrobial agents. The Lyme disease spirochete was most susceptible to ceftriaxone (MBC, 0.04 microgram/ml) and erythromycin (MBC, 0.05 microgram/ml), then tetracycline (MBC, 0.8 microgram/ml), and finally penicillin G (MBC, 6.4 micrograms/ml). Syrian hamsters were used to determine the 50% curative doses (CD50s) of the four antimicrobial agents. Ceftriaxone and tetracycline had the highest activities, with CD50s of 24.0 and 28.7 mg/kg [corrected], respectively. Both erythromycin and penicillin G possessed low activities. The CD50 of erythromycin was 235.3 mg/kg [corrected], and the CD50 of penicillin G was greater than 197.5 mg/kg [corrected].

Antimicrob Agents Chemother. 1987 February; 31(2): 164-167




This article has been cited by other articles:

  • Wormser, G. P., Schwartz, I. (2009). Antibiotic Treatment of Animals Infected with Borrelia burgdorferi. Clin. Microbiol. Rev. 22: 387-395 [Abstract] [Full Text]  
  • Selby, G, Bridges, S J, Hanington, L (2008). SHOULD LYME DISEASE AFFECTING THE NERVOUS SYSTEM BE TREATED WITH ORAL OR INTRAVENOUS ANTIBIOTICS?. EDUCATION AND PRACTICE 93: 132-134 [Full Text]  
  • Terekhova, D., Sartakova, M. L., Wormser, G. P., Schwartz, I., Cabello, F. C. (2002). Erythromycin Resistance in Borrelia burgdorferi. Antimicrob. Agents Chemother. 46: 3637-3640 [Abstract] [Full Text]  
  • Pavia, C., Inchiosa, M. A. Jr, Wormser, G. P. (2002). Efficacy of Short-Course Ceftriaxone Therapy for Borrelia burgdorferi Infection in C3H Mice. Antimicrob. Agents Chemother. 46: 132-134 [Abstract] [Full Text]  
  • Haake, D. A. (2000). Spirochaetal lipoproteins and pathogenesis. Microbiology 146: 1491-1504 [Full Text]  
  • Nowakowski, J., McKenna, D., Nadelman, R. B., Cooper, D., Bittker, S., Holmgren, D., Pavia, C., Johnson, R. C., Wormser, G. P. (2000). Failure of Treatment With Cephalexin for Lyme Disease. Arch Fam Med 9: 563-567 [Abstract] [Full Text]  
  • Murgia, R., Marchetti, F., Cinco, M. (1999). Comparative Bacteriostatic and Bactericidal Activities of Cefodizime against Borrelia burgdorferi Sensu Lato. Antimicrob. Agents Chemother. 43: 3030-3032 [Abstract] [Full Text]  
  • Dattwyler, R. J., Luft, B. J., Kunkel, M. J., Finkel, M. F., Wormser, G. P., Rush, T. J., Grunwaldt, E., Agger, W. A., Franklin, M., Oswald, D., Cockey, L., Maladorno, D. (1997). Ceftriaxone Compared with Doxycycline for the Treatment of Acute Disseminated Lyme Disease. NEJM 337: 289-295 [Abstract] [Full Text]  
  • Nadelman, R. B., Luger, S. W., Frank, E., Wisniewski, M., Collins, J. J., Wormser, G. P. (1992). Comparison of Cefuroxime Axetil and Doxycycline in the Treatment of Early Lyme Disease. ANN INTERN MED 117: 273-280 [Abstract]  
  • Kaslow, R. A. (1992). Current Perspective on Lyme Borreliosis. JAMA 267: 1381-1383 [Abstract]  
  • Rahn, D. W., Malawista, S. E. (1991). Lyme Disease: Recommendations for Diagnosis and Treatment. ANN INTERN MED 114: 472-481 [Abstract]  
  • Caperton, E. M., Heim-Duthoy, K. L., Matzke, G. R., Peterson, P. K., Johnson, R. C. (1990). Ceftriaxone Therapy of Chronic Inflammatory Arthritis. Arch Intern Med 150: 1677-1682 [Abstract]  
  • Pfister, H.-W., Preac-Mursic, V., Wilske, B., Einhaupl, K. M. (1989). Cefotaxime vs Penicillin G for Acute Neurologic Manifestations in Lyme Borreliosis: A Prospective Randomized Study. Arch Neurol 46: 1190-1194 [Abstract]  
  • Finkel, M. F. (1988). Lyme Disease and Its Neurologic Complications. Arch Neurol 45: 99-104 [Abstract]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»